Akeso Biopharma, Co., Ltd

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Akeso Biopharma, Co., Ltd is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Akeso Biopharma, Co., Ltd

Akeso Biopharma, Co., Ltd is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by PENPULIMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: metastatic non-keratinizing, treatment adults, nasopharyngeal carcinoma, either cisplatin, single agent, disease progression, platinum-based chemotherapy, least one. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
PENPULIMAB 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Akeso Biopharma, Co., Ltd

Brand nameGenericTypeRoute
Penpulimab kcqx PENPULIMAB HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Akeso Biopharma, Co., Ltd make?
1 FDA drug label records name Akeso Biopharma, Co., Ltd as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Akeso Biopharma, Co., Ltd produce?
The most frequent active ingredients in this portfolio are PENPULIMAB.

Are Akeso Biopharma, Co., Ltd products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.